SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories gets nod to incorporate subsidiary in Chile

12 Feb 2026 Evaluate

Zim Laboratories has received approval to incorporate a wholly owned subsidiary in in Chile, LATAM region namely ‘ZIM Laboratories SpA’ or any other name as approved by the regulatory authority, with an investment of upto $15,000. The incorporation of wholly owned subsidiary is with an objective of expansion and development of business in the LATAM region. The board of directors of the company in its meeting held on February 11, 2026, have considered and approved the same.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.

Zim Laboratories Share Price

72.32 -0.75 (-1.03%)
13-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.00
Cipla 1211.30
Zydus Lifesciences 920.00
Lupin 2316.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×